COMPANY DESCRIPTION
Lubrizol, a Berkshire Hathaway company, is a science-based company whose specialty chemistry delivers sustainable solutions to advance mobility, improve well-being, and enhance modern life. Every day, the innovators of Lubrizol strive to create extraordinary value for customers at the intersection of science, market needs, and business success, driving discovery and creating breakthrough solutions that aim to enhance life and make the world work better. Lubrizol offers a wide range of solutions and technologies across several industries, with a strong focus on innovation, sustainability, and performance. Its solutions for the pharmaceutical industry enhance drug delivery, stability, and efficacy, supporting the development of safe and effective medications that improve patient outcomes.
COMPANY BACKGROUND
Lubrizol was founded in 1928. Its initial success came from developing a graphite lubricant and applicator for early automobiles, but it expanded into a diversified specialty chemical company. Headquartered in Wickliffe, Ohio, it now has global reach and local presence, with over 100 manufacturing facilities, sales and technical offices, and over 7,000 employees worldwide.
MARKETS SERVED
Lubrizol partners with pharmaceutical and nutraceutical companies to develop innovative solutions that improve patient outcomes and offer consumer benefits. As well as polymer-based excipients for the solubility, bioavailability, and palatability of APIs and nutraceuticals, it offers expertise and capabilities to help companies accelerate their innovations to market.
PRODUCTS, SERVICES & CAPABILITIES
Lubrizol’s products include:
ApisolexTM Polymer Excipient: a polyamino acid-based polymer excipient for injectable and parenteral drug formulations with the potential for creating life-changing therapies. It can enhance the solubility of APIs 50,000-fold, with other benefits including high drug loading.
ApinovexTM Polymer Excipient: Designed to enhance the solubility of BCS Class II and IV APIs for the development of more efficient oral dosage forms, the benefits of ApinovexTM Polymer Excipient include high drug-loading (up to 80%) and up to 10x improvement in the dissolution of crystalline APIs.
Carbopol® Polymer Excipient: Suitable for a range of formulations, including topical and oral applications, Carbopol® polymer excipient has been used by the pharmaceutical and nutraceutical industries for over six decades. Its benefits include improved delivery of active ingredients in oral drug formulations.